Dorly de Freitas Buchi

Homeopathy Science

About Us

Dorly de Freitas Buchi, a renowned Brazilian researcher, holds a Ph.D. in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro. Her solid academic background is reflected in the publication of several scientific articles in the field of Cell Biology. Professor, for more than 40 years at the Federal University of Paraná, she combines extensive experience in higher education, both in undergraduate and graduate courses, and effective contributions in the sphere of the university administration. Her orientation activities are remarkable, from scientific initiation to doctorate, having promoted the training of a large number of young scientists.

Despite this exemplary academic trajectory, what makes Dorly a special human being are her unique qualities: loyalty, courage, tenderness, and tenacity. Woman, mother, sister, and friend, she is endowed with profound sensitivity, a conciliatory spirit, and the ability to aggregate people and ideals around a greater good. Her respect for life, in all its forms, has always guided her in search of health promotion and a better life for all. And so, in her continuous overcoming of challenges, guided by an acute scientific curiosity and her non-conformity with the paradigms and limitations of traditional medicine, in an untiring spirit and an unwavering purpose of serving collective interests, firmly carried out research based on highly diluted drugs and complex biological response modifiers. A significant part of the results of her efforts and her holistic view is presented in this book which, as an author, proposes to contribute to life, health, and the construction of happiness for all.

About Homeopathy

Immune System and Homeopathy Studies using macrophages treated with different homeopathic medicines have resulted in a significant increase in the activated/resident macrophage ratio compared to control groups (water, hydroalcoholic solution, and untreated). Different macrophage receptors were altered, both in expression and distribution, in addition to altering the production and release of different cytokines and reactive oxygen and nitrogen species…

Last posts we sent to the blog

Homeopathy Science

  • Like cures like: This principle states that a substance that can cause symptoms in a healthy person can cure those same symptoms in a sick person. For example, if a person gets a rash from contact with poison ivy, then a homeopathic remedy made from poison ivy might be used to treat a rash with similar symptoms.

  • The law of minimums: This principle states that the smaller the dose of a remedy, the greater its effect. Homeopathic remedies are often diluted to very high levels, but practitioners believe that this dilution makes them more effective.

  • The single remedy: This principle states that only one remedy should be given at a time, so that its effects can be clearly observed.

  • The totality of symptoms: This principle states that the remedy should be chosen based on the whole picture of the patient’s symptoms, not just the physical symptoms. This includes the patient’s emotional and mental state, as well as their lifestyle and preferences.

My Book on Amazon

To know more about homeoptahy

Visit our blog

The existence and unexpected pathways in my life.

In this book, I tell the story of my life and my relationship with science, and especially how this journey resulted in 20 years of basic research in homeopathy.

Address

Gallusstrasse 1a 8730 Uznach

Email

buchi@imagem.ch

Recent studies demonstrate that homeopathic medicines may contain a source of silica nanoparticles because of their traditional manufacturing processes.

In a paper published in 1801, Hahnemann mentioned the prophylactic properties of Belladonna for the treatment of scarlet fever as well as the method of preparation for Belladonna to 1/24,000,000 dilution. He wrote, “we dissolve a grain (1 grain = 0.06479891 grams) of this powder in one hundred drops of common distilled water…, and render the union perfect, by diligently shaking the liquid, …and so on… and this is our prophylactic remedy for scarlet fever, each drop of which contains the twenty-four millionth part of a grain of the dry belladonna juice.”

Hahnemann recommended the administration of one drop which is equivalent to 0.0416 nanograms of Belladonna and to repeat the dose every 72 hours. This is the first recorded nanodose of medicine used in the
treatment of any disease in medical history.

For more than two centuries homeopathy medicine has been the world’s second most practiced therapy.

It becomes so popular due to its simple fabrication, easy availability, cost-effectiveness, and easier applicability, though the reason behind the effectiveness of homeopathy is still a mystery. Homeopathic medicines are active at extreme dilution (dilution factor even beyond 10-400).

This fact has been difficult to be accepted by the conventional scientific community, which leads to the stance that these medicines have only a placebo effect.

However, a large number of placebo-controlled plant, animal, and cellular studies indicate that remedies exert effects distinct from placebo. Different scientists propose different theories such as water memory, quantum-electrodynamics (QED), nanoparticle aspect, etc., and they concluded that homeopathic medicines reach nanoscale range by potentization, i.e., serial dilution with systematic succussion.

And also, some researchers showed that the permeability of the biological membrane gets affected due to the size variation of homeopathic drugs (see previous posts here: Epigenetics and Epigenetics II).

The significance of finding nanoparticles in homeopathic remedies is that NPS has very different properties from those of their respective bulk form materials, as a function of their small size.

NPS are not merely small versions of their respective bulk forms. Nano sizing by mechanical milling of drugs leads to (a) greater bioavailability with improved absorption; (b) higher adsorptive capacity to attach other nanomaterials onto their surfaces and serve as drug, vaccine, or gene delivery vehicles.

A nanoparticle (NP) is a body having a size on the order of 100 nanometers (0.1 microns). 100 nanometers correspond to the wavelength of ultraviolet radiation radiating in the range of 10 to 380 nanometers. For example, electromagnetic waves visible to the human eye (visible light) are included in wavelengths from 0.38 to 0.78 microns, 380 nanometers for violet, 780 nanometers for red.

Nanoparticles have interesting properties because, on the nanoparticle scale, the physical attributes of these properties are different from the original material.

Nanoparticle research focuses on the benefits and performance of the product on this scale. This is known as nanoscience, the study of phenomena and manipulation of matter at atomic, molecular and macromolecular scales, where properties differ significantly from those prevailing on a larger scale. Nanoforms of drugs, herbs, nutriceuticals, and vaccines can all produce biological effects.

NPs are more atom-like in behavior, acquiring the different electrical, magnetic, thermal, optical, chemical, biological, and quantum effects compared with their bulk forms. For instance, Gold, which is non-magnetic in bulk form, becomes magnetic in nanoparticle form.

Hahnemann recommended the administration of one drop which is equivalent to 0.0416 nanograms of Belladonna and to repeat the dose every 72 hours. This is the first recorded nanodose of medicine used in the
treatment of any disease in medical history.

The significance of finding nanoparticles in homeopathic remedies, which is an answer, result in many more questions. Much work is needed to understand the practical and therapeutic implications of these hypotheses.

As said, Dr. Peter Fisher:

Nevertheless taken together with the papers in this special issue mark a major theoretical advance in the understanding of homeopathy and a major step to overcoming plausibility bias: the prejudice that homeopathy does not work because it cannot work.

Antibodies adsorption to a particle.

You can read more in:

Frontiers in Bioscience (Scholar Edition) 2013; 5(2): 685-708 Iris R. Bell and Gary E. Schwartz

Dorly de Freitas Buchi